Immunocore Plc

(NASDAQ) IMCR

Current Price$29.96

Market Cap$1.55B

Since IPO (2021)-29%

5 Year-24%

1 Year+2%

1 Month-4%

Immunocore Plc Financials at a Glance

Market Cap

$1.55B

Revenue (TTM)

$385.76M

Net Income (TTM)

$18.82M

EPS (TTM)

$-0.56

P/E Ratio

-54.58

Dividend

$0.00

Beta (Volatility)

0.77 (Low)

Dividend

$0.00

Beta (Volatility)

0.77 (Low)

Price

$29.96

Volume

50,153.895

Open

$30.62

Price

$29.96

Volume

50,153.895

Open

$30.62

Previous Close

$30.62

Daily Range

$29.80 - $30.65

52-Week Range

$27.44 - $40.71

Dividend

$0.00

Beta (Volatility)

0.77 (Low)

Price

$29.96

Volume

50,153.895

Open

$30.62

Previous Close

$30.62

Daily Range

$29.80 - $30.65

52-Week Range

$27.44 - $40.71

IMCR News

Immunocore (IMCR) Q2 Revenue Jumps 30%

Motley Fool Markets TeamAug 7, 2025

What's Winning in 2022? 3 Stocks That Are Doing Fine

Taylor CarmichaelJul 16, 2022

IMCR: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Immunocore Plc

Industry

Biotechnology

Sector

Health Care

Employees

524

CEO

Bahija Jallal, PhD

Website

immunocore.com

Headquarters

Abingdon, OX14 4RY, GB

IMCR Financials

Key Financial Metrics (TTM)

Gross Margin

99%

Operating Margin

-8%

Net Income Margin

-5%

Return on Equity

-7%

Return on Capital

-4%

Return on Assets

-2%

Earnings Yield

-1.83%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.55B

Shares Outstanding

50.69M

Volume

50.15K

Avg. Volume

397.01K

Financials (TTM)

Gross Profit

$291.36M

Operating Income

$33.74M

EBITDA

$387.18K

Operating Cash Flow

$7.97M

Capital Expenditure

$3.23M

Free Cash Flow

$11.20M

Cash & ST Invst.

$864.15M

Total Debt

$43.56M

Immunocore Plc Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$106.68M

+13.6%

Gross Profit

$106.24M

+14.2%

Gross Margin

99.59%

N/A

Market Cap

$1.55B

N/A

Market Cap/Employee

$3.15M

N/A

Employees

493

N/A

Net Income

$12.97M

+158.2%

EBITDA

$7.28M

-26.9%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$802.87M

+99.2%

Accounts Receivable

$81.07M

+28.5%

Inventory

$8.25M

+21.3%

Long Term Debt

$40.03M

-90.7%

Short Term Debt

$2.00M

+16.2%

Return on Assets

-1.76%

N/A

Return on Invested Capital

-3.53%

N/A

Free Cash Flow

$15.56M

-11454.7%

Operating Cash Flow

$13.78M

-3266.7%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

ABCLAbCellera Biologics Inc.

ABCLAbCellera Biologics Inc.$5.04+4.46%

NUVBNuvation Bio Inc.

NUVBNuvation Bio Inc.$4.78-0.62%

HRMYHarmony Biosciences Holdings, Inc.

HRMYHarmony Biosciences Holdings, Inc.$31.52+0.32%

SIONSionna Therapeutics, Inc.

SIONSionna Therapeutics, Inc.$44.49+2.74%

XERSXeris Biopharma Holdings, Inc.

XERSXeris Biopharma Holdings, Inc.$6.38-3.85%

MNKDMannKind Corporation

MNKDMannKind Corporation$3.46-2.68%

BHVNBiohaven Ltd.

BHVNBiohaven Ltd.$9.81+0.82%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

RXTRackspace Technology

RXTRackspace Technology$5.30+0.51%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$15.52+0.07%

IRENIren

IRENIren$60.55+0.07%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$75.67+0.06%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$42.99-0.06%

INTCIntel

INTCIntel$125.89+0.15%

NVDANvidia

NVDANvidia$215.60+0.02%

Questions About IMCR

What is the current price of Immunocore Plc?

Immunocore Plc is trading at $29.96 per share.

What is the 52-week range for Immunocore Plc?

Over the past 52 weeks, Immunocore Plc has traded between $27.44 and $40.71.

How much debt does Immunocore Plc have?

As of the most recent reporting period, Immunocore Plc reported total debt of $435.68M.

How much cash does Immunocore Plc have on hand?

Immunocore Plc reported $452.68M in cash and cash equivalents in its most recent financial results.

What is Immunocore Plc’s dividend yield?

Immunocore Plc does not currently have a dividend yield.

Immunocore Plc

Immunocore Plc Financials at a Glance

IMCR News

Immunocore (IMCR) Q2 Revenue Jumps 30%

What's Winning in 2022? 3 Stocks That Are Doing Fine

IMCR: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Immunocore Plc

IMCR Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Immunocore Plc Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About IMCR

What is the current price of Immunocore Plc?

What is the 52-week range for Immunocore Plc?

How much debt does Immunocore Plc have?

How much cash does Immunocore Plc have on hand?

What is Immunocore Plc’s dividend yield?

Premium Investing Services